News

Highly active antiretroviral therapy (HAART) has had a dramatic impact on the health of individuals infected with HIV, but some patients experience problems while receiving HAART and may

The selected compound is currently in preclinical studies and, based on the successful completion of the preclinical program, Cytokinetics intends to submit a regulatory filing for the initiation

The FDA granted final approval to the company’s abbreviated new drug application for the generic OxyContin (oxycodone hydrochloride) controlled release 80mg tablets in late September 2004. Impax agreed

In 2004, Labopharm signed an agreement with CSC under which it granted CSC the exclusive right to market and sell Labopharm’s once-daily formulation of the pain drug tramadol

The new label for Thyrogen (thyrotropin alfa for injection) permits the product’s use in the EU for the ablation of remnant thyroid tissue, a procedure that patients commonly

The taste of liquid remedies or the sight of pills often send children burrowing beneath their covers and can be messy or difficult for children to take. Children’s

The phase II clinical trial is a multi-center, open-label study to evaluate the efficacy, safety and tolerability of HGS-ETR1 (mapatumumab), an agonistic human monoclonal antibody to TRAIL receptor

Orathecin (rubitecan) is an orally active camptothecin that is being developed for the treatment of pancreatic cancer and gemcitabine is a chemotherapy drug sold under the brand name

This collaboration builds on the initial R&D conducted by Corixa and Apovia for the development of a therapeutic vaccine for the treatment of hepatitis B. Lorantis has acquired